Lenalidomide Impurity 41 | CAS 764-28-3 - Request Quote
Lenalidomide Impurity 41
| SZ CAT No: | SZ-L031060 |
| CAS No | 764-28-3 |
| Mol.F. | C8H12N4 |
| Mol.Wt. | 164.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Lenalidomide Impurity 41 is chemically (E)-3,3'-(Diazene-1,2-diyl)bis(2-methylpropanenitrile). Lenalidomide Impurity 41 is supplied with detailed characterization data compliant with regulatory guideline. Lenalidomide Impurity 41 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lenalidomide.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 764-28-3
Purchase 764-28-3
Order 764-28-3
Enquire 764-28-3
price of 764-28-3
764-28-3 Supplier
764-28-3 Manufacturer
764-28-3 Exporter
buy high quality Lenalidomide Impurity 41
Purchase Lenalidomide Impurity 41
Lenalidomide Impurity 41 suppliers
Lenalidomide Impurity 41 manufacturers
Lenalidomide Impurity 41 price
Order Lenalidomide Impurity 41
Enquire Lenalidomide Impurity 41
Lenalidomide Impurity 41 cost
Lenalidomide Impurity 41 Supplier
Lenalidomide Impurity 41 Distributor
Lenalidomide Impurity 41 for Method Validation
Lenalidomide Reference Standard
Lenalidomide Impurity 41 for ANDA Filing
Lenalidomide Impurity 41 for Forced Degradation Studies
Lenalidomide Impurity 41 Identification Standards
Lenalidomide Impurity 41 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


